|
NFYC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.33379999997818E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.30610000000664E-05 |
| Normal-vs-Stage2 |
1.187760E-02 |
| Normal-vs-Stage3 |
1.581870E-04 |
| Normal-vs-Stage4 |
6.264300E-03 |
| Stage1-vs-Stage2 |
6.060000E-01 |
| Stage1-vs-Stage3 |
3.995600E-01 |
| Stage1-vs-Stage4 |
6.507800E-01 |
| Stage2-vs-Stage3 |
3.049400E-01 |
| Stage2-vs-Stage4 |
4.883200E-01 |
| Stage3-vs-Stage4 |
9.343800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.71461999999289E-05 |
| Normal-vs-AfricanAmerican |
5.7197999999925E-05 |
| Normal-vs-Asian |
5.369600E-02 |
| Caucasian-vs-AfricanAmerican |
8.996600E-01 |
| Caucasian-vs-Asian |
8.545800E-01 |
| AfricanAmerican-vs-Asian |
8.090400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01519999995414E-06 |
| Normal-vs-Female |
1.460070E-03 |
| Male-vs-Female |
4.228000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.570900E-04 |
| Normal-vs-Extreme_Weight |
1.963860E-04 |
| Normal-vs-Obese |
1.00830000004937E-06 |
| Normal-vs-Extreme_Obese |
1.323000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.146200E-01 |
| Normal_Weight-vs-Obese |
3.494200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.925200E-01 |
| Extreme_Weight-vs-Obese |
2.403200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.212800E-01 |
| Obese-vs-Extreme_Obese |
8.368500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.363800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.962700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.17410000000095E-06 |
| Normal-vs-Age(81-100Yrs) |
5.94449999999913E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.439400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.387000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.554200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.923700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.880200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.76500000000002E-05 |
| Normal-VS-Type2 PRCC |
1.53659999946321E-07 |
| Normal-VS-KIRP CIMP |
4.58150000048896E-07 |
| Normal-VS-Unclassified PRCC |
3.905800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.641800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.194870E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.308000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.666100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.377800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.67787999999502E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.03570000000464E-05 |
| Normal-vs-N1 |
7.54040000000566E-05 |
| Normal-vs-N2 |
9.064500E-03 |
| N0-vs-N1 |
3.479800E-01 |
| N0-vs-N2 |
2.383200E-01 |
| N1-vs-N2 |
5.072400E-01 |
|
|
